VANCOUVER, BC / ACCESSWIRE / November 15, 2024 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) ("CoTec" or the "Company") is pleased to announce it has filed its unaudited interim condensed consolidate ...
Kadestone Capital Corp. (TSXV: KDSX) (OTCQB: KDCCF) ("Kadestone" or the "Company"), a vertically integrated property company, today ...
VANCOUVER, BC, Nov. 14, 2024 /CNW/ - Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) ("Africa Energy" or the "Company"), an oil and gas exploration company, announces corporate update ...
Positive working capital of $9.9 million at September 30, 2024, a $16.0 million improvement compared to December 31, 2023.Adjusted refinery operations segment margin of $1.3 million for the nine month ...
MCLEAN, VA / ACCESSWIRE / November 15, 2024 / Gladstone Commercial Corporation (Nasdaq:GOOD) (the "Company") announced that Terry Lee Brubaker will be retiring as Chief Operating Officer of the Compan ...
MCLEAN, VA / ACCESSWIRE / November 15, 2024 / Gladstone Capital Corporation (NASDAQ:GLAD) (the "Company") announced that Terry Lee Brubaker will be retiring as Chief Operating Officer of the Company e ...
TAMPA, FL / ACCESSWIRE / November 15, 2024 / Generation Income Properties, Inc. (NASDAQ:GIPR) ("GIPR" or the "Company") today announced its three and nine month financial and operating results for the ...
Q3 2024 sales revenue increased 164% year-over-year to $135 thousand.Sequential (quarter-over-quarter) net product revenue growth of 8.3%.Gross profit increased from ($20 thousand) to $24 thousand. WA ...
Reports 60% Increase in ARR to $17.6 Million, Positive Net Income and Cash Flow, Adjusted EBITDA of $1.3 Million HENDERSON, Nev., Nov. 14, 2024 /PRNewswire/ -- Research Solutions, Inc.
Q4 revenue of $838 million increased 10% compared to prior year; organic revenue decreased 1% Q4 GAAP EPS of $0.17 decreased from $0.24 in the prior year; adjusted ...
HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved functional ...